Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Christian Freudlsperger, Jeffrey R Burnett, Jay A Friedman, Vishnu R Kannabiran, Zhong Chen & Carter Van Waes. (2011) EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy. Expert Opinion on Therapeutic Targets 15:1, pages 63-74.
Read now
Read now
Lev Bromberg. (2005) Intelligent hydrogels for the oral delivery of chemotherapeutics. Expert Opinion on Drug Delivery 2:6, pages 1003-1013.
Read now
Read now
Articles from other publishers (14)
Li-Jie Li, Chien-Hsiu Li, Peter Mu-Hsin Chang, Tsung-Ching Lai, Chen-Yin Yong, Sheng-Wei Feng, Michael Hsiao, Wei-Min Chang & Chi-Ying F. Huang. (2022) Dehydroepiandrosterone (DHEA) Sensitizes Irinotecan to Suppress Head and Neck Cancer Stem-Like Cells by Downregulation of WNT Signaling. Frontiers in Oncology 12.
Crossref
Crossref
Corbin D. Jacobs, Michael J. Moravan, Jennifer Choe, Russel Kahmke, Yvonne Mowery & Joseph K. Salama. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Petr Szturz & Jan B. Vermorken. 2016. Head and Neck Cancer. Head and Neck Cancer
711
729
.
Cristina P. Rodriguez & David J. Adelstein. 2016. Head and Neck Cancer. Head and Neck Cancer
337
348
.
Katharine A. R. Price & Ezra E. Cohen. (2012) Current Treatment Options for Metastatic Head and Neck Cancer. Current Treatment Options in Oncology 13:1, pages 35-46.
Crossref
Crossref
Jan B. Vermorken. 2011. Head and Neck Cancer. Head and Neck Cancer
651
664
.
Cristina P. Rodriguez & David J. Adelstein. 2011. Head and Neck Cancer. Head and Neck Cancer
281
291
.
J.B. Vermorken & P. Specenier. (2010) Optimal treatment for recurrent/metastatic head and neck cancer. Annals of Oncology 21, pages vii252-vii261.
Crossref
Crossref
S. Marur & A. A. Forastiere. (2010) Update on role of chemotherapy in head and neck squamous cell cancer. Indian Journal of Surgical Oncology 1:2, pages 85-95.
Crossref
Crossref
Athanassios Argiris, Ashley Buchanan, Bruce Brockstein, Jill Kolesar, Musie Ghebremichael, Michael Pins, Kristine Hahn, Rita Axelrod & Arlene Forastiere. (2009) Docetaxel and irinotecan in recurrent or metastatic head and neck cancer. Cancer 115:19, pages 4504-4513.
Crossref
Crossref
William N. William, Joseph L. Lee, Dong M. Shin, Waun K. Hong, Suyu Liu, J Jack Lee, Scott M. Lippman, Fadlo R. Khuri & Edward S. Kim. (2009) Phase I Trial of Weekly Topotecan and Gemcitabine in Patients With Solid Tumors. American Journal of Clinical Oncology 32:1, pages 15-19.
Crossref
Crossref
A. Machaira, E. Tsiambas, K. Goula, E. Chrysomali, O. Nikolatou, L. Manaios, A.D. Rapidis, A. Karameris & E. Patsouris. (2008) Different topoisomerase IIa protein expression patterns affect prognosis in tongue squamous cell carcinoma: a quantitative digital image analysis study. Oral Surgery 1:3, pages 117-124.
Crossref
Crossref
Claudio Pisano, Valentina Zuco, Michelandrea De Cesare, Valentina Benedetti, Loredana Vesci, Rosanna Foderà, Federica Bucci, Concetta Aulicino, Sergio Penco, Paolo Carminati & Franco Zunino. (2008) Intracellular accumulation and DNA damage persistence as determinants of human squamous cell carcinoma hypersensitivity to the novel camptothecin ST1968. European Journal of Cancer 44:9, pages 1332-1340.
Crossref
Crossref
A. Dimitrios Colevas. (2006) Chemotherapy Options for Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck. Journal of Clinical Oncology 24:17, pages 2644-2652.
Crossref
Crossref